Recent media releases/statements on new prescription-only medicines (POMs), issued by the UK Department of Health and Social Care and its executive NHS agencies, risks spurning the strict regulations on the promotion of these drugs, warns Dr. James Cave, editor in chief of the Drug and Therapeutics Bulletin (DTB), now in its 60th year, in this month’s edition.